Difference between revisions of "NONHSAT091315"
Line 3: | Line 3: | ||
==Annotated Information== | ==Annotated Information== | ||
===Name=== | ===Name=== | ||
− | ''TUSC7'': Tumor suppressor candidate 7 (HGNC nomenclature), LOC285194 <ref name="ref1" />. | + | ''TUSC7'': Tumor suppressor candidate 7 (HGNC nomenclature), also known as LOC285194, LSAMP antisense RNA 3 <ref name="ref1" /><ref name="ref4" />. |
===Characteristics=== | ===Characteristics=== | ||
− | ''TUSC7'' is four exon transcript of 2105 bp long noncoding RNA, located on the focal region of human chromosome chr3q13.31 (osteo3q13.31) <ref name="ref1" />. Exon 4 harbors two miR-211 binding sites <ref name="ref4" />. | + | ''TUSC7'' is four exon transcript of 2105 bp long noncoding RNA, located on the focal region of human chromosome chr3q13.31 (osteo3q13.31) <ref name="ref1" /><ref name="ref4" />. Exon 4 harbors two miR-211 binding sites <ref name="ref4" />. |
− | |||
− | |||
− | |||
− | |||
===Function=== | ===Function=== | ||
Together with the other noncoding RNA ''BC040587'' and the tumor suppressor gene ''LSAMP'' (limbic system-associated membrane protein) present in focal region (osteo3q13.31), ''TUSC7'' cooperatively acting as tumor suppressor genes <ref name="ref1" />. | Together with the other noncoding RNA ''BC040587'' and the tumor suppressor gene ''LSAMP'' (limbic system-associated membrane protein) present in focal region (osteo3q13.31), ''TUSC7'' cooperatively acting as tumor suppressor genes <ref name="ref1" />. | ||
Line 31: | Line 27: | ||
===Regulation=== | ===Regulation=== | ||
− | + | ''p53'' transcriptionally regulates the ''TUSC7'' by direct binding to its promoter region <ref name="ref4" />. | |
− | |||
===Disease=== | ===Disease=== | ||
Line 44: | Line 39: | ||
* Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.<ref name="ref2" /> | * Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.<ref name="ref2" /> | ||
* Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.<ref name="ref3" /> | * Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.<ref name="ref3" /> | ||
+ | * Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, IL, USA.<ref name="ref4" /> | ||
+ | * Institute of Neuroscience, Chongqing Medical University, Chongqing 400016, PR China.<ref name="ref4" /> | ||
+ | * Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA.<ref name="ref4" /> | ||
+ | * Department of Endocrinology, PLA General Hospital, Beijing 100853, PR China.<ref name="ref4" /> | ||
==References== | ==References== |
Revision as of 08:42, 22 November 2018
Please input one-sentence summary here.
Contents
Annotated Information
Name
TUSC7: Tumor suppressor candidate 7 (HGNC nomenclature), also known as LOC285194, LSAMP antisense RNA 3 [1][2].
Characteristics
TUSC7 is four exon transcript of 2105 bp long noncoding RNA, located on the focal region of human chromosome chr3q13.31 (osteo3q13.31) [1][2]. Exon 4 harbors two miR-211 binding sites [2].
Function
Together with the other noncoding RNA BC040587 and the tumor suppressor gene LSAMP (limbic system-associated membrane protein) present in focal region (osteo3q13.31), TUSC7 cooperatively acting as tumor suppressor genes [1].
Depletion of TUSC7 by siRNA promoted proliferation of normal osteoblasts (with a mild increase in the G1 population) by cell-cycle transcripts (Cyclin D1, VEGF, and VEGFR1 up-regulation, and cyclin A2 and cyclin B1 suppression) as well as regulation of apoptotic genes (such as suppression of BCL2 and BimEL pro-apoptotic genes) [1].
Expression
TUSC7 is significantly downregulated in Colorectal cancer tissues [3][4].
Experiment | Forward primer | Reverse primer |
---|---|---|
qRT-PCR | 5’-GGAAACAGAAGGCACCTCA-3’ | 5’-TCTCAGAGGTCAAACAGGCA-3’[4] |
Regulation
p53 transcriptionally regulates the TUSC7 by direct binding to its promoter region [2].
Disease
Labs working on this lncRNA
- Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.[3]
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.[3]
- Institute of Pathology, Fudan University, Shanghai, 200032, China.[3]
- Institutes of Biomedical Sciences, Fudan University, Shanghai, 200032, China.[3]
- Department of Colorectal Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.[4]
- Department of Medical Microbiology, Immunology and Cell Biology, Southern Illinois University School of Medicine, Springfield, IL, USA.[2]
- Institute of Neuroscience, Chongqing Medical University, Chongqing 400016, PR China.[2]
- Cancer Institute, University of Mississippi Medical Center, Jackson, MS, USA.[2]
- Department of Endocrinology, PLA General Hospital, Beijing 100853, PR China.[2]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Pasic I, Shlien A, Durbin AD, Stavropoulos DJ, Baskin B, Ray PN et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13. 31 in osteosarcoma[J]. Cancer research. 2010, 70(1): 160-171.
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z et al. LncRNA loc285194 is a p53-regulated tumor suppressor[J]. Nucleic acids research. 2013, 41(9): 4976-4987.
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Qi P, Xu MD, Ni SJ, Huang D, Wei P, Tan C et al. Low expression of LOC285194 is associated with poor prognosis in colorectal cancer[J]. Journal of translational medicine. 2013, 11(1):122.
- ↑ 4.0 4.1 4.2 4.3 Xu J, Zhao J, Zhang R. The novel long noncoding RNA TUSC7 inhibits proliferation by sponging MiR-211 in colorectal cancer[J]. Cellular physiology and biochemistry. 2017, 41(2):635-644.
Sequence
>gi|285194|ref|NR_015391.1| Homo sapiens tumor suppressor candidate 7 (TUSC7), long non-coding RNA
000081 TTGCTAGAGG TAGGAAGATG ATAAGATCAG TTTCTATAGG TAGAGGATAA TGTGTCCTAA AATGTAGGTA GAGATAAGTC 000160
000161 TGACAGTGGT TTAGACAAAA AGGGCCTCTG CTAATGGTGG AGAGATCAAG GAAGAAAAGA GCAACGTTAA AGTGAGGCTG 000240
000241 TACCCACAGA TCATGCTCAA GCAAATTCGA ACCGTGAGCG CATTTCTCTT AAACAATGAA CACTTAGAAT AAAAATTAAA 000320
000321 ATTTCCCACA AATTTCTAAT TTTAAAATAG TTTCCCAAGA TTTCAGTGGT ATTGTATATA TGCCCATATA ATTTTTTGGA 000400
000401 TTACTATTCC CACAAGTGTA AGATGAAAGA GGACCTGCCC TCCATTCTAT CTACTCCCTC TCTGCAAAGG CCATTTTGAA 000480
000481 GATCTCAGTT TTACTGAAAG GGGTCTGCCA CACATAACTT CCCTGGTGTA CCAGCAACAA GTGTTCAGTG GACCATGGCA 000560
000561 ACACAAAGAA TGACGGAGGA GAGAAAATGC CATGCAGAAG TGATAGTCAA GATGAAGATG TGGGAGAGGA GCAGCCCCCA 000640
000641 GTATATATTC AGTGTGTCCT CTGAAGTAAC AACCATCCCA TCTGGCTGAG AAGTGATGGA CACGGCTCCT TAACCACACT 000720
000721 GTACCCTCTG TTCTTGGCAC CTCTCTACCA GAAAGATATC AACAAATTGG ATGGAATTCA GAGAACAGTA AGAAAAATGA 000800
000801 TTAAAGAGAT GGAGGCAGTG ACTTATGAGG AAAGATGAAA AGGACTAAAT CTATGTAGCT TGGCAAAGCA ACAACTGAGG 000880
000881 TGGCGTATGA AAACTGTCTA CAAGCATTTG AAGAATATAA ACACCAAGGG AAGAGAGGGA ACTTTTTAGA ATGGTCTGGG 000960
000961 GAATAAGCAG AGTAAGAGGA CAGAATTGAA GAAAGGAGAG AGATATGCTA AGTTGGGGGT GGGGGCGTTT TCTCATCAAT 001040
001041 TGTAAATTTT GATAAATAAC AAAATTAAGT CTGGAGAGAA AGAGTTGCAT CTCATGCTTT TAGGTTACAA TCAGTGTTGA 001120
001121 CCTGCACTGA GAAAATGTGA CTTCCTATTA TCCTTCTCAA AGTTATTGCT GCAGAGGAAA GAAGCATACA TCTTTTACCC 001200
001201 ACCAGGAAAC CCCCAAAGCA TCTATTACCA TAATAGCCAT GGGAAACAGA AGGCACCTCA AATAAAGGTG GGGAAAAGAA 001280
001281 TGAAAGAAAT GGCTTTGGCC TGTGCCTGTT TGACCTCTGA GAGATACTTT TTGCAAGAAA TTGTTAAGTT TTGGCCCAAA 001360
001361 AAGTGGTCGG TCTTTTATCC TTCCTTGTGG AGGCCAAACT GCAAACCAGG ATGAAGAAAC CATCAGTGGC AGTTTGGGGA 001440
001441 GGTGGAGGAG GGACTATCTA GACTCAGTGA ATCACCAAGG AAACATGAGG CCTATTTCTC TGTGAAGCTG AACTTCAAAA 001520
001521 AACAATCTAA GAGATACAAA GGGAAAAGTG TGACTGCTCT GACAGCAAAA ACAAGCAAAT ATCTCCAGAG GGGATTAATC 001600
001601 CTTCTGCTTC AAAGTAACTA AAACAAAGAA AGCTGAGCCA GCTTCACTGG AAACAACACC TGTCCATCAG ACAAGGATGA 001680
001681 GCTAATCAAA AGAAAACACT GCCTATGTGC ACGACTCAGC AGCCTGGACA GCTAATACCA AGGAACACGT TTTCACTATA 001760
001761 AAGATTCAGC TTTCAAAATC CAGTTCCCTC TTGTAGAGCC ACAGGGTTAA AAGGGACCTT AGAGATCATC TACATACAGG 001840
001841 CCAAACCCTC AATGAATGCC AGTGTTCGCC TTATGTTCTT CTTGCCGGAC TCTTTTCTGG CCTCTGTTCT GTCAGGATGT 001920
001921 TTCCTGTTTT GCAAAACAGC TTTAATCCTT GAGTATATTT AATTGTTAGA AAACAGTTCC TCAAATTTGA CCCCAAATTT 002000
002001 AAGTCTAATT TATGAAGAAA GTTTTGCCTT TGGAGACAGG TTTAATTTTA CTTCCATGTG GAAAACCTTC AAATAAAATG 002080
002081 ATGACTATTG TGTACTCACG AAAAA
Predicted Small Protein
Name | NONHSAT091315_smProtein_554:688 |
Length | 45 |
Molecular weight | 5090.8545 |
Aromaticity | 0.0681818181818 |
Instability index | 79.2 |
Isoelectric point | 7.94122314453 |
Runs | 9 |
Runs residual | 0.0414438502674 |
Runs probability | 0.0412569432178 |
Amino acid sequence | MATQRMTEERKCHAEVIVKMKMWERSSPQYIFSVSSEVTTIPSG |
Secondary structure | LLLLLLLHHHLEEEEEEEEEEEEEELLLEEEEEELLEEEEELLL |
PRMN | - |
PiMo | - |